<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rpmj</journal-id><journal-title-group><journal-title xml:lang="ru">Research'n Practical Medicine Journal</journal-title><trans-title-group xml:lang="en"><trans-title>Research and Practical Medicine Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2410-1893</issn><publisher><publisher-name>"QUASAR", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17709/2410-1893-2021-8-3-11</article-id><article-id custom-type="elpub" pub-id-type="custom">rpmj-683</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Review</subject></subj-group></article-categories><title-group><article-title>О механизмах противоопухолевого действия соединений трополонового ряда</article-title><trans-title-group xml:lang="en"><trans-title>On mechanisms of antitumor action of tropolon series compounds</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8832-8219</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жукова</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukova</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жукова Галина Витальевна – д.б.н., старший научный сотрудник испытательного лабораторного центра, SPIN: 1887-7415, AuthorID: 564827, Researcher ID: Y-4243-2016,Scopus Author ID: 7005456284</p><p>344037, г. Ростов-на-Дону, ул. 14-я линия, д. 63</p></bio><bio xml:lang="en"><p>Galina V. Zhukova – Dr. Sci. (Biol.), senior researcher at the testing laboratory center, SPIN: 1887-7415, AuthorID: 564827, Researcher ID: Y-4243-2016, Scopus Author ID: 7005456284</p><p>63 14 line str., Rostov-on-Don 344037</p></bio><email xlink:type="simple">galya_57@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3036-6199</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукбанова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukbanova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лукбанова Екатерина Алексеевна – научный сотрудник испытательного лабораторного центра, SPIN: 4078-4200, AuthorID: 837861, Scopus Author ID: 57215860146</p><p>344037, г. Ростов-на-Дону, ул. 14-я линия, д. 63</p></bio><bio xml:lang="en"><p>Ekaterina A. Lukbanova – researcher at the testing laboratory center, SPIN: 4078-4200, AuthorID: 837861, Scopus Author ID: 57215860146</p><p>63 14 line str., Rostov-on-Don 344037</p></bio><email xlink:type="simple">katya.samarskaja@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6364-1794</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Протасова</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Protasova</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Протасова Татьяна Пантелеевна – к.б.н., научный сотрудник испытательного лабораторного центра, SPIN: 4542-3588, AuthorID: 760427</p><p>344037, г. Ростов-на-Дону, ул. 14-я линия, д. 63</p></bio><bio xml:lang="en"><p>Tatyana P. Protasova – Cand. Sci. (Biol.), researcher at the testing laboratory center, SPIN: 4542-3588, AuthorID: 760427</p><p>63 14 line str., Rostov-on-Don 344037</p></bio><email xlink:type="simple">protasovatp@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0088-2990</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Заикина</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaikina</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Заикина Екатерина Владиславовна – младший научный сотрудник испытательного лабораторного центра, SPIN: 4000-4369, AuthorID: 1045258</p><p>344037, г. Ростов-на-Дону, ул. 14-я линия, д. 63</p></bio><bio xml:lang="en"><p>Ekaterina V. Zaikina – junior researcher at the testing laboratory center, SPIN: 4000-4369, AuthorID: 1045258</p><p>63 14 line str., Rostov-on-Don 344037</p></bio><email xlink:type="simple">katherine_bio@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9337-5535</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киблицкая</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kiblitskaya</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Киблицкая Александра Андреевна – научный сотрудник испытательного лабораторного центра </p><p>344037, г. Ростов-на-Дону, ул. 14-я линия, д. 63</p></bio><bio xml:lang="en"><p>Aleksandra A. Kiblitskaya – researcher at the testing laboratory center </p><p>63 14 line str., Rostov-on-Don 344037</p></bio><email xlink:type="simple">kibaleand@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ онкологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre for Oncology of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>23</day><month>09</month><year>2021</year></pub-date><volume>8</volume><issue>3</issue><fpage>118</fpage><lpage>132</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Жукова Г.В., Лукбанова Е.А., Протасова Т.П., Заикина Е.В., Киблицкая А.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Жукова Г.В., Лукбанова Е.А., Протасова Т.П., Заикина Е.В., Киблицкая А.А.</copyright-holder><copyright-holder xml:lang="en">Zhukova G.V., Lukbanova E.A., Protasova T.P., Zaikina E.V., Kiblitskaya A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpmj.ru/rpmj/article/view/683">https://www.rpmj.ru/rpmj/article/view/683</self-uri><abstract><p>В обзоре приведены сведения о механизмах противоопухолевого действия природных и синтетических соединений трополонового ряда, полученные в течение последних 30 лет в исследованиях на культурах клеток и, в меньшей степени, в экспериментах in vivo. Интерес к данной группе веществ обусловлен острой потребностью клинической онкологии в средствах, эффективно повреждающих злокачественные клетки и, одновременно, безопасных для здоровых тканей. Наиболее полно изучены процессы, реализующие эффекты колхицина, хинокитиола (ß-туйяплицина) и некоторых их дериватов (производные бистрополона, α-замещенные трополоны и др). При этом были выявлены более многочисленные механизмы реализации противоопухолевого действия хинокитиола и его производных по сравнению с колхицином. Помимо нарушения формирования веретена деления, показанного для колхицина и колхамина, описаны такие явления, как каспазо-зависимый апоптоз и некоторые другие виды апоптоза, аутофагия, ограничение митохондриального метаболизма, повреждение и деметилирование ДНК, ускоренное старение малигнизированных клеток и проч. Показана перспективность использовавния производных 2‑хинолил 1,3‑трополона и связь их противоопухолевого действия с индукцией апоптоза и изменением активности сигнального пути ERK в некоторых типах малигнизированных клеток. Полученные результаты свидетельствуют о многообразии возможных путей влияния трополонов на состояние злокачественных клеток, условия реализации каждого из которых нуждаются в уточнении, особенно при дефиците сведений о процессах in vivo.</p><p>В обзоре использованы сведения литературы, представленной в базах данных Scopus, WoS, Pubmed. 35 % работ опубликовано за последние 5 лет.</p></abstract><trans-abstract xml:lang="en"><p>The review provides information on the mechanisms of the antitumor action of natural and synthetic compounds of the tropolone series, obtained over the past 30 years in studies on cell cultures and, to a lesser extent, in in vivo experiments. Interest in this group of substances is due to the urgent need of clinical oncology for drugs that effectively damage malignant cells and, at the same time, are safe for healthy tissues. The processes that realize the effects of colchicine, hinokithiol (ß-tuyaplicin) and some of their derivatives (derivatives of bistropolone, α-substituted tropolones, etc.) have been studied most fully. Herewith, more numerous mechanisms of realization of the antitumor effect of hinokithiol and its derivatives were revealed in comparison with colchicine. In addition to the disruption in the formation of the cell division spindle, shown for colchicine and colchamine, such phenomena as caspase-dependent apoptosis and some other types of apoptosis, autophagy, limitation of mitochondrial metabolism, DNA damage and demethylation, and accelerated aging of malignant cells etc. have been described. The promising properties of 2‑quinolyl 1,3‑tropolone derivatives have been shown, and the relationship of their antitumor effect with the induction of apoptosis and changes in the activity of the ERK signaling pathway in some types of malignant cells have been revealed. The results indicate a multiplicity of possible ways of the influence of tropolones on the state of malignant cells, the conditions for the implementation of ones need to be clarified, especially with a lack of information about in vivo processes.</p><p>The review includes information from the literature presented in the Scopus, WoS, Pubmed databases. 35 % of articles have been published in the last 5 years.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>трополоны</kwd><kwd>злокачественные клетки</kwd><kwd>ксенографты опухолей человека</kwd><kwd>ингибирование злокачественного роста</kwd><kwd>апоптоз</kwd><kwd>аутофагия</kwd><kwd>клеточный цикл</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tropolones</kwd><kwd>malignant cells</kwd><kwd>xenografts of human tumors</kwd><kwd>inhibition of malignant growth</kwd><kwd>apoptosis</kwd><kwd>autophagy</kwd><kwd>cell cycle</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа проведена при поддержке ФГБУ «НМИЦ онкологии» Минздрава России</funding-statement><funding-statement xml:lang="en">. The work was supported by the National Medical Research Centre for Oncology of the Ministry of Health of Russia</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Qu N, Itoh M, Sakabe K. Effects of Chemotherapy and Radiotherapy on Spermatogene-sis: The Role of Testicular Immunology. Int J Mol Sci. 2019 Feb 22;20(4):957. https://doi.org/10.3390/ijms20040957</mixed-citation><mixed-citation xml:lang="en">Qu N, Itoh M, Sakabe K. Effects of Chemotherapy and Radiotherapy on Spermatogenesis: The Role of Testicular Immunology. Int J Mol Sci. 2019 Feb 22;20(4):957. https://doi.org/10.3390/ijms20040957</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Damia G, Broggini M. Platinum Resistance in Ovarian Cancer: Role of DNA Repair. Cancers (Basel). 2019 Jan 20;11(1):119. https://doi.org/10.3390/cancers11010119</mixed-citation><mixed-citation xml:lang="en">Damia G, Broggini M. Platinum Resistance in Ovarian Cancer: Role of DNA Repair. Cancers (Basel). 2019 Jan 20;11(1):119. https://doi.org/10.3390/cancers11010119</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Varricchi G, Ameri P, Cadeddu C, Ghigo A, Madonna R, Marone G, et al. Antineo-plastic Drug-Induced Cardiotoxicity: A Redox Perspective. Front Physiol. 2018;9:167. https://doi.org/10.3389/fphys.2018.00167</mixed-citation><mixed-citation xml:lang="en">Varricchi G, Ameri P, Cadeddu C, Ghigo A, Madonna R, Marone G, et al. Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective. Front Physiol. 2018;9:167. https://doi.org/10.3389/fphys.2018.00167</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кит О.И., Шихлярова А.И., Жукова Г.В., Марьяновская Г.Ю., Барсукова Л.П., Ко-робейникова Е.П. и др. Теоретические и прикладные аспекты активационной терапии. Cardiometry. 2015;7:22–29. https://doi.org/10.12710/cardiometry.2015.7.2229</mixed-citation><mixed-citation xml:lang="en">Kit OI, Shikhlyarova AI, Zhukova GV, Maryanovskaya GY, Barsukova LP, Korobeinikova EP, et al. Activation therapy: theoretical and applied aspects. Cardiometry. 2015;7:22–29. (In Russian). https://doi.org/10.12710/cardiometry.2015.7.2229</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Сагакянц А.Б. Объединенный иммунологический форум: современные направле-ния развития фундаментальной и прикладной онкоиммунологии (Новосибирск, 2019). Южно-Российский онкологический журнал. 2020;1(2):36–45. https://doi.org/10.37748/2687-0533-2020-1-2-5</mixed-citation><mixed-citation xml:lang="en">Sagakyants A.B. United immunological forum: current trends in the development of fundamental and applied oncoimmunology (Novosibirsk, 2019). South Russian Journal of Cancer. 2020;1(2):36-45. (In Russian). https://doi.org/10.37748/2687-0533-2020-1-2-5</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lloyd D. Carbocyclic Non-Benzenoid Aromatic Compounds. Elsevier. Amsterdam-London-New-York. 1966, 220 p.</mixed-citation><mixed-citation xml:lang="en">Lloyd D. Carbocyclic Non-Benzenoid Aromatic Compounds. Elsevier. Amsterdam-London-New-York. 1966, 220 p.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Yamauchi H. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Biochem Biophys Res Commun. 2006 Dec 8;351(1):26–32. https://doi.org/10.1016/j.bbrc.2006.09.166</mixed-citation><mixed-citation xml:lang="en">Liu S, Yamauchi H. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Biochem Biophys Res Commun. 2006 Dec 8;351(1):26–32. https://doi.org/10.1016/j.bbrc.2006.09.166</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Li L-H, Wu P, Lee J-Y, Li P-R, Hsieh W-Y, Ho C-C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS One. 2014;9(8):e104203. https://doi.org/10.1371/journal.pone.0104203</mixed-citation><mixed-citation xml:lang="en">Li L-H, Wu P, Lee J-Y, Li P-R, Hsieh W-Y, Ho C-C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS One. 2014;9(8):e104203. https://doi.org/10.1371/journal.pone.0104203</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ononye SN, Vanheyst MD, Giardina C, Wright DL, Anderson AC. Studies on the anti-proliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells. Bioorg Med Chem. 2014 Apr 1;22(7):2188–2193. https://doi.org/10.1016/j.bmc.2014.02.018</mixed-citation><mixed-citation xml:lang="en">Ononye SN, Vanheyst MD, Giardina C, Wright DL, Anderson AC. Studies on the antiproliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells. Bioorg Med Chem. 2014 Apr 1;22(7):2188–2193. https://doi.org/10.1016/j.bmc.2014.02.018</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bang DN, Sayapin YA, Lam H, Duc ND, Komissarov VN. Synthesis and cytotoxic activ-ity of [benzo[b][1,4]oxazepino[7,6,5-de]quinolin-2-yl]-1,3-tropolones. Chem Heterocycl Comp. 2015 Mar 1;51(3):291–294. https://doi.org/10.1007/s10593-015-1697-2</mixed-citation><mixed-citation xml:lang="en">Bang DN, Sayapin YA, Lam H, Duc ND, Komissarov VN. Synthesis and cytotoxic activity of [benzo[b][1,4]oxazepino[7,6,5-de] quinolin-2-yl]-1,3-tropolones. Chem Heterocycl Comp. 2015 Mar 1;51(3):291–294. https://doi.org/10.1007/s10593-015-1697-2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tkachev VV, Sayapin YuA, Tupaeva IO, Gusakov EA, Shilov GV, Aldoshin SM, et al. Structure of 2-(benzoxazole-2-Yl)- 5,7-di(tert-butyl)-4-nitro-1,3-tropolone. J Struct Chem. 2018 Jan 1;59(1):197–200. https://doi.org/10.1134/S0022476618010316</mixed-citation><mixed-citation xml:lang="en">Tkachev VV, Sayapin YuA, Tupaeva IO, Gusakov EA, Shilov GV, Aldoshin SM, et al. Structure of 2-(benzoxazole-2-Yl)- 5,7-di(tert-butyl)-4-nitro-1,3-tropolone. J Struct Chem. 2018 Jan 1;59(1):197–200. https://doi.org/10.1134/S0022476618010316</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao J. Plant troponoids: chemistry, biological activity, and biosynthesis. Curr Med Chem. 2007;14(24):2597–2621. https://doi.org/10.2174/092986707782023253</mixed-citation><mixed-citation xml:lang="en">Zhao J. Plant troponoids: chemistry, biological activity, and biosynthesis. Curr Med Chem. 2007;14(24):2597–2621. https://doi.org/10.2174/092986707782023253</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Shih Y-H, Chang K-W, Hsia S-M, Yu C-C, Fuh L-J, Chi T-Y, et al. In vitro antimicrobi-al and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines. Mi-crobiol Res. 2013 Jun 12;168(5):254–262. https://doi.org/10.1016/j.micres.2012.12.007</mixed-citation><mixed-citation xml:lang="en">Shih Y-H, Chang K-W, Hsia S-M, Yu C-C, Fuh L-J, Chi T-Y, et al. In vitro antimicrobial and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines. Microbiol Res. 2013 Jun 12;168(5):254–262. https://doi.org/10.1016/j.micres.2012.12.007</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Elagawany M, Hegazy L, Cao F, Donlin MJ, Rath N, Tavis J, et al. Identification of 4-isopropyl–thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characteriza-tion, and biological evaluation. RSC Adv. 2018 Aug 20;8(52):29967–29975. https://doi.org/10.1126/science.2475911</mixed-citation><mixed-citation xml:lang="en">Elagawany M, Hegazy L, Cao F, Donlin MJ, Rath N, Tavis J, et al. Identification of 4-isopropyl–thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characterization, and biological evaluation. RSC Adv. 2018 Aug 20;8(52):29967– 29975. https://doi.org/10.1126/science.2475911</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Çankaya N, Bulduk İ, Çolak AM. Extraction, development and validation of HPLC-UV method for rapid and sensitive determination of colchicine from Colchicum autumnale L. Bulbs. Saudi J Biol Sci. 2019 Feb;26(2):345–351. https://doi.org/10.1016/j.sjbs.2018.10.003</mixed-citation><mixed-citation xml:lang="en">Çankaya N, Bulduk İ, Çolak AM. Extraction, development and validation of HPLC-UV method for rapid and sensitive determination of colchicine from Colchicum autumnale L. Bulbs. Saudi J Biol Sci. 2019 Feb;26(2):345–351. https://doi.org/10.1016/j.sjbs.2018.10.003</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bhattacharyya B, Panda D, Gupta S, Banerjee M. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Med Res Rev. 2008 Jan;28(1):155–183. https://doi.org/10.1002/med.20097</mixed-citation><mixed-citation xml:lang="en">Bhattacharyya B, Panda D, Gupta S, Banerjee M. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Med Res Rev. 2008 Jan;28(1):155–183. https://doi.org/10.1002/med.20097</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Alkadi H, Khubeiz MJ, Jbeily R. Colchicine: A Review on Chemical Structure and Clin-ical Usage. Infect Disord Drug Targets. 2018;18(2):105–121. https://doi.org/10.2174/1871526517666171017114901</mixed-citation><mixed-citation xml:lang="en">Alkadi H, Khubeiz MJ, Jbeily R. Colchicine: A Review on Chemical Structure and Clinical Usage. Infect Disord Drug Targets. 2018;18(2):105–121. https://doi.org/10.2174/1871526517666171017114901</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Бурбаева Г.Ш., Андросова Л.В., Савушкина О.К. Связывание колхицина с тубули-ном в структурах головного мозга в норме и при шизофрении. Нейрохимия. 2020;37(2):183–187. https://doi.org/10.31857/S1027813320010069</mixed-citation><mixed-citation xml:lang="en">Burbaeva GSh, Androsova LV, Savushkina OK. Binding of colchicine to tubulin in the brain structuresin normal conditions and in schizophrenia. Neurochemical Journal. 2020;37(2):183– 187. (In Russian). https://doi.org/10.31857/S1027813320010069</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Maldonado EN, Patnaik J, Mullins MR, Lemasters JJ. Free tubulin modulates mito-chondrial membrane potential in cancer cells. Cancer Res. 2010 Dec 15;70(24):10192–10201. https://doi.org/10.1158/0008-5472.CAN-10-2429</mixed-citation><mixed-citation xml:lang="en">Maldonado EN, Patnaik J, Mullins MR, Lemasters JJ. Free tubulin modulates mitochondrial membrane potential in cancer cells. Cancer Res. 2010 Dec 15;70(24):10192–10201. https://doi.org/10.1158/0008-5472.CAN-10-2429</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lin Z-Y, Kuo C-H, Wu D-C, Chuang W-L. Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines. Kaohsiung J Med Sci. 2016 Feb;32(2):68–73. https://doi.org/10.1016/j.kjms.2015.12.006</mixed-citation><mixed-citation xml:lang="en">Lin Z-Y, Kuo C-H, Wu D-C, Chuang W-L. Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines. Kaohsiung J Med Sci. 2016 Feb;32(2):68–73. https://doi.org/10.1016/j.kjms.2015.12.006</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kurek J, Kwaśniewska-Sip P, Myszkowski K, Cofta G, Barczyński P, Murias M, et al. Antifungal, anticancer, and docking studies of colchiceine complexes with monovalent metal cation salts. Chem Biol Drug Des. 2019 Sep;94(5):1930–1943. https://doi.org/10.1111/cbdd.13583</mixed-citation><mixed-citation xml:lang="en">Kurek J, Kwaśniewska-Sip P, Myszkowski K, Cofta G, Barczyński P, Murias M, et al. Antifungal, anticancer, and docking studies of colchiceine complexes with monovalent metal cation salts. Chem Biol Drug Des. 2019 Sep;94(5):1930–1943. https://doi.org/10.1111/cbdd.13583</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Florian S, Mitchison TJ. Anti-Microtubule Drugs. Methods Mol Biol. 2016;1413:403–421. https://doi.org/10.1007/978-1-4939-3542-0_25</mixed-citation><mixed-citation xml:lang="en">Florian S, Mitchison TJ. Anti-Microtubule Drugs. Methods Mol Biol. 2016;1413:403–421. https://doi.org/10.1007/978-1-4939-3542-0_25</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Matsumura E, Morita Y, Date T, Tsujibo H, Yasuda M, Okabe T, et al. Cytotoxicity of the hinokitiol-related compounds, gamma-thujaplicin and beta-dolabrin. Biol Pharm Bull. 2001 Mar;24(3):299–302. https://doi.org/10.1248/bpb.24.299</mixed-citation><mixed-citation xml:lang="en">Matsumura E, Morita Y, Date T, Tsujibo H, Yasuda M, Okabe T, et al. Cytotoxicity of the hinokitiol-related compounds, gamma-thujaplicin and beta-dolabrin. Biol Pharm Bull. 2001 Mar;24(3):299–302. https://doi.org/10.1248/bpb.24.299</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Максимов А.Ю., Лукбанова Е.А., Саяпин Ю.А., Гусаков Е.А., Гончарова А.С., Лы-сенко И.Б. и др. Противоопухолевая активность алкалоидов трополонового ряда in vitro и in vivo. Современные проблемы науки и образования. 2020:(2);169. https://doi.org/10.17513/spno.29722</mixed-citation><mixed-citation xml:lang="en">Maksimov AYu, Lukbanova EA, Sayapin YA, Gusakov EA, Goncharova AS, Lysenko IB, et al. Anticancer activity of tropolone alkaloids in vitro and in vivo. Modern problems of science and education. 2020;(2)169. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lee Y-S, Choi K-M, Kim W, Jeon Y-S, Lee Y-M, Hong J-T, et al. Hinokitiol inhibits cell growth through induction of S-phase arrest and apoptosis in human colon cancer cells and suppresses tumor growth in a mouse xenograft experiment. J Nat Prod. 2013 Dec 27;76(12):2195–2202. https://doi.org/10.1021/np4005135</mixed-citation><mixed-citation xml:lang="en">Lee Y-S, Choi K-M, Kim W, Jeon Y-S, Lee Y-M, Hong J-T, et al. Hinokitiol inhibits cell growth through induction of S-phase arrest and apoptosis in human colon cancer cells and suppresses tumor growth in a mouse xenograft experiment. J Nat Prod. 2013 Dec 27;76(12):2195–2202. https://doi.org/10.1021/np4005135</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Seo JS, Choi YH, Moon JW, Kim HS, Park S-H. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells. BMC Cell Biol. 2017 Feb 27;18(1):14. https://doi.org/10.1186/s12860-017-0130-3</mixed-citation><mixed-citation xml:lang="en">Seo JS, Choi YH, Moon JW, Kim HS, Park S-H. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells. BMC Cell Biol. 2017 Feb 27;18(1):14. https://doi.org/10.1186/s12860-017-0130-3</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S-M, Wang B-Y, Lee C-H, Lee H-T, Li J-J, Hong G-C, et al. Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells. Oncotarget. 2017 Sep 29;8(44):76057–76068. https://doi.org/10.18632/oncotarget.18648</mixed-citation><mixed-citation xml:lang="en">Chen S-M, Wang B-Y, Lee C-H, Lee H-T, Li J-J, Hong G-C, et al. Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells. Oncotarget. 2017 Sep 29;8(44):76057–76068. https://doi.org/10.18632/oncotarget.18648</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang G, He J, Ye X, Zhu J, Hu X, Shen M, et al. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signal-ing in human hepatocellular carcinoma. Cell Death Dis. 2019 Mar 15;10(4):255. https://doi.org/10.1038/s41419-019-1492-6</mixed-citation><mixed-citation xml:lang="en">Zhang G, He J, Ye X, Zhu J, Hu X, Shen M, et al. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma. Cell Death Dis. 2019 Mar 15;10(4):255. https://doi.org/10.1038/s41419-019-1492-6</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Morita Y, Matsumura E, Tsujibo H, Yasuda M, Okabe T, Sakagami Y, et al. Biological activity of 4-acetyltropolone, the minor component of Thujopsis dolabrata SIeb. et Zucc. hon-dai Mak. Biol Pharm Bull. 2002 Aug;25(8):981–985. https://doi.org/10.1248/bpb.25.981</mixed-citation><mixed-citation xml:lang="en">Morita Y, Matsumura E, Tsujibo H, Yasuda M, Okabe T, Sakagami Y, et al. Biological activity of 4-acetyltropolone, the minor component of Thujopsis dolabrata SIeb. et Zucc. hondai Mak. Biol Pharm Bull. 2002 Aug;25(8):981–985. https://doi.org/10.1248/bpb.25.981</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ido Y, Muto N, Inada A, Kohroki J, Mano M, Odani T, et al. Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3. Cell Prolif. 1999 Feb;32(1):63–73. https://doi.org/10.1046/j.1365-2184.1999.3210063.x</mixed-citation><mixed-citation xml:lang="en">Ido Y, Muto N, Inada A, Kohroki J, Mano M, Odani T, et al. Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3. Cell Prolif. 1999 Feb;32(1):63–73. https://doi.org/10.1046/j.1365-2184.1999.3210063.x</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Li L-H, Wu P, Lee J-Y, Li P-R, Hsieh W-Y, Ho C-C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS One. 2014;9(8):e104203. https://doi.org/10.1371/journal.pone.0104203</mixed-citation><mixed-citation xml:lang="en">Li L-H, Wu P, Lee J-Y, Li P-R, Hsieh W-Y, Ho C-C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS One. 2014;9(8):e104203. https://doi.org/10.1371/journal.pone.0104203</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Peng Y, Uray IP, Shen J, Wang L, Peng X, et al. Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy. DNA Repair (Amst). 2017 Dec;60:89–101. https://doi.org/10.1016/j.dnarep.2017.10.009</mixed-citation><mixed-citation xml:lang="en">Zhang L, Peng Y, Uray IP, Shen J, Wang L, Peng X, et al. Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy. DNA Repair (Amst). 2017 Dec;60:89–101. https://doi.org/10.1016/j.dnarep.2017.10.009</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Yamauchi H. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Biochem Biophys Res Commun. 2006 Dec 8;351(1):26–32. https://doi.org/10.1016/j.bbrc.2006.09.166</mixed-citation><mixed-citation xml:lang="en">Liu S, Yamauchi H. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Biochem Biophys Res Commun. 2006 Dec 8;351(1):26–32. https://doi.org/10.1016/j.bbrc.2006.09.166</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Tu D-G, Yu Y, Lee C-H, Kuo Y-L, Lu Y-C, Tu C-W, et al. Hinokitiol inhibits vasculo-genic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor. Oncol Lett. 2016 Apr;11(4):2934–2940. https://doi.org/10.3892/ol.2016.4300</mixed-citation><mixed-citation xml:lang="en">Tu D-G, Yu Y, Lee C-H, Kuo Y-L, Lu Y-C, Tu C-W, et al. Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor. Oncol Lett. 2016 Apr;11(4):2934–2940. https://doi.org/10.3892/ol.2016.4300</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C-H, Jayakumar T, Chang C-C, Fong T-H, Lu S-H, Thomas PA, et al. Hinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture. Molecules. 2015 Sep 25;20(10):17720–17734. https://doi.org/10.3390/molecules201017720</mixed-citation><mixed-citation xml:lang="en">Huang C-H, Jayakumar T, Chang C-C, Fong T-H, Lu S-H, Thomas PA, et al. Hinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture. Molecules. 2015 Sep 25;20(10):17720–17734. https://doi.org/10.3390/molecules201017720</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Tsao Y-T, Huang Y-F, Kuo C-Y, Lin Y-C, Chiang W-C, Wang W-K, et al. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells. Int J Mol Sci. 2016 Feb 18;17(2):248. https://doi.org/10.3390/ijms17020248</mixed-citation><mixed-citation xml:lang="en">Tsao Y-T, Huang Y-F, Kuo C-Y, Lin Y-C, Chiang W-C, Wang W-K, et al. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells. Int J Mol Sci. 2016 Feb 18;17(2):248. https://doi.org/10.3390/ijms17020248</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ahn J-H, Woo J-H, Rho J-R, Choi J-H. Anticancer Activity of Gukulenin A Isolated from the Marine Sponge Phorbas gukhulensis In Vitro and In Vivo. Mar Drugs. 2019 Feb 21;17(2):126. https://doi.org/10.3390/md17020126</mixed-citation><mixed-citation xml:lang="en">Ahn J-H, Woo J-H, Rho J-R, Choi J-H. Anticancer Activity of Gukulenin A Isolated from the Marine Sponge Phorbas gukhulensis In Vitro and In Vivo. Mar Drugs. 2019 Feb 21;17(2):126. https://doi.org/10.3390/md17020126</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Yamato M, Ando J, Sakaki K, Hashigaki K, Wataya Y, Tsukagoshi S, et al. Synthesis and antitumor activity of tropolone derivatives. 7. Bistropolones containing connecting meth-ylene chains. J Med Chem. 1992 Jan 24;35(2):267–273. https://doi.org/10.1021/jm00080a010</mixed-citation><mixed-citation xml:lang="en">Yamato M, Ando J, Sakaki K, Hashigaki K, Wataya Y, Tsukagoshi S, et al. Synthesis and antitumor activity of tropolone derivatives. 7. Bistropolones containing connecting methylene chains. J Med Chem. 1992 Jan 24;35(2):267–273. https://doi.org/10.1021/jm00080a010</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ishihara M, Wakabayashi H, Motohashi N, Sakagami H. Quantitative structure-cytotoxicity relationship of newly synthesized tropolones determined by a semiempirical mo-lecular-orbital method (PM5). Anticancer Res. 2010 Jan;30(1):129–133.</mixed-citation><mixed-citation xml:lang="en">Ishihara M, Wakabayashi H, Motohashi N, Sakagami H. Quantitative structure-cytotoxicity relationship of newly synthesized tropolones determined by a semiempirical molecular-orbital method (PM5). Anticancer Res. 2010 Jan;30(1):129–133.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Ononye SN, Vanheyst MD, Giardina C, Wright DL, Anderson AC. Studies on the anti-proliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells. Bioorg Med Chem. 2014 Apr 1;22(7):2188–2193. https://doi.org/10.1016/j.bmc.2014.02.018</mixed-citation><mixed-citation xml:lang="en">Ononye SN, Vanheyst MD, Giardina C, Wright DL, Anderson AC. Studies on the antiproliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells. Bioorg Med Chem. 2014 Apr 1;22(7):2188–2193. https://doi.org/10.1016/j.bmc.2014.02.018</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Falcone ER, Holstein SA, Anderson AC, Wright DL, Wiemer AJ. Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis. Pharmacol Res. 2016 Nov;113(Pt A):438–448. https://doi.org/10.1016/j.phrs.2016.09.020</mixed-citation><mixed-citation xml:lang="en">Li J, Falcone ER, Holstein SA, Anderson AC, Wright DL, Wiemer AJ. Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis. Pharmacol Res. 2016 Nov;113(Pt A):438–448. https://doi.org/10.1016/j.phrs.2016.09.020</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Haney SL, Allen C, Varney ML, Dykstra KM, Falcone ER, Colligan SH, et al. Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells. Oncotarget. 2017 Sep 29;8(44):76085–76098. https://doi.org/10.18632/oncotarget.18543</mixed-citation><mixed-citation xml:lang="en">Haney SL, Allen C, Varney ML, Dykstra KM, Falcone ER, Colligan SH, et al. Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells. Oncotarget. 2017 Sep 29;8(44):76085–76098. https://doi.org/10.18632/oncotarget.18543</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Iwatsuki M, Takada S, Mori M, Ishiyama A, Namatame M, Nishihara-Tsukashima A, et al. In vitro and in vivo antimalarial activity of puberulic acid and its new analogs, viticolins A-C, produced by Penicillium sp. FKI-4410. J Antibiot (Tokyo). 2011 Feb;64(2):183–188. https://doi.org/10.1038/ja.2010.124</mixed-citation><mixed-citation xml:lang="en">Iwatsuki M, Takada S, Mori M, Ishiyama A, Namatame M, Nishihara-Tsukashima A, et al. In vitro and in vivo antimalarial activity of puberulic acid and its new analogs, viticolins A-C, produced by Penicillium sp. FKI-4410. J Antibiot (Tokyo). 2011 Feb;64(2):183–188. https://doi.org/10.1038/ja.2010.124</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Bang DN, Sayapin YA, Lam H, Duc ND, Komissarov VN. Synthesis and cytotoxic activ-ity of [benzo[b][1,4]oxazepino[7,6,5-de]quinolin-2-yl]-1,3-tropolones. Chem Heterocycl Comp. 2015;51(3):291–294. https://doi.org/10.1007/s10593-015-1697-2</mixed-citation><mixed-citation xml:lang="en">Bang DN, Sayapin YA, Lam H, Duc ND, Komissarov VN. Synthesis and cytotoxic activity of [benzo[b][1,4]oxazepino[7,6,5-de] quinolin-2-yl]-1,3-tropolones. Chem Heterocycl Comp. 2015;51(3):291–294. https://doi.org/10.1007/s10593-015-1697-2</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Gusakov EA, Topchu IA, Mazitova AM, Dorogan IV, Bulatov ER, Serebriiskii IG, et al. Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents. RSC Adv. 2021;11(8):4555–4571. https://doi.org/10.1039/d0ra10610k</mixed-citation><mixed-citation xml:lang="en">Gusakov EA, Topchu IA, Mazitova AM, Dorogan IV, Bulatov ER, Serebriiskii IG, et al. Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents. RSC Adv. 2021;11(8):4555–4571. https://doi.org/10.1039/d0ra10610k</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Thieffry D. Dynamical roles of biological regulatory circuits. Brief Bioinform. 2007 Jul;8(4):220–225. https://doi.org/10.1093/bib/bbm028</mixed-citation><mixed-citation xml:lang="en">Thieffry D. Dynamical roles of biological regulatory circuits. Brief Bioinform. 2007 Jul;8(4):220–225. https://doi.org/10.1093/bib/bbm028</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
